Skin and serum reactivity among humans to histoplasmin in the vicinity of a natural focus of Histoplasma capsulatum var. duboisii

Mycopathologia

Volumn 134, Issue 2, 1996, Pages 71-74

  Muotoe Okafor, Florence A ^a   Gugnani, Harish C ^a   Gugnani, Anupama ^a  

^a UNIVERSITY OF NIGERIA   (Nigeria)

Author keywords

bat cave; Histoplasma capsulatum var. duboisii; histoplasmin skin sensitivity; human population; immunodiffusion; natural Nigerian focus; precipitating antibodies

Indexed keywords

EID: 0030471872     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00436867     Document Type: Article

References (20)

1. Ajello L. Histoplasmosis - a dual entity; histoplasmosis capsulati and histoplasmosis duboisii. L'Igiene Moderna 1983; 3-30.
2. Rippon JW. Medical Mycology, The Pathogenic Fungi and Actinomycetes. Philadelphia: W.B. Saunders, 1988; 424-432.
3. Coulanges P, Raveloarism G, Ravisse P. Existence de l'histoplasmose à Histoplasma duboisii en dehors de l'Afrique continental (à propos du premier cas magalache). Bull Soc Path Exot Filiales 1982; 75: 400-403.
4. Gugnani HC. The pattern of deep mycoses in Nigeria. W Afr Med J 1983; 2: 67-71.
5. Muotoe-Okafor FA. Aspects of the ecology, pathogenicity and physiology of Histoplasma capsulatum var. duboisii and some other pathogenic fungi. Ph.D. thesis 1995, University of Nigeria, Nsukka, Nigeria.
6. Gatti F, Vroey Cd. African histoplasmosis. In: Gatti F et al. (eds), Human Mycoses in Tropical Countries, 2nd ed. Bologna, Italy: Health Cooperation Papers, O.C.S.I, 1991; 211-218.
7. Delormas P, Roux F, Schol R. L'histoplasmose en Cote d'Ivoire. Une enquête epidemiologique par test à l'histoplasmine. Path Biol 1965; 13: 285-287.
8. Ogunbi O, Njoku-Obi ANU. Histoplasmin survey of school children in Lagos, Nigeria. West Afr Med J 1972; 24: 246-248.
9. Bezak V, Farsey SJ. Prevalence of skin sensitivity to histoplasmin and coccidioidin in various Ugandan populations. Amer J Trop Med Hyg 1970; 19: 664-669.
10. Imperato PJ, Diallo S, Sow O. Histoplasmin sensitivity in the inland delta of Niger. Trop Geog Med 1972; 24: 246-248.
11. Nuti M, Tarabini C, Adorisio E, Zardi O. Histoplasmosis diffusion in Somalia. Study of skin test and serological survey. Biochem Exper Biol 1980; 15: 111-118.
12. Gugnani HC, Egere JU, Larsh H. Skin sensitivity to capsulatum and duboisii histoplasmin in Nigeria. J Trop Med Hyg 1991; 94: 24-26.
13. Gugnani HC, Muotoe-Okafor FA, Kaufinan L, Dupont B. A natural focus of Histoplasma capsulatum var. duboisii in a bat cave. Mycopathologia 1994; 127: 151-157.
14. Pine L, Grose H, Breadléy-Malcom G, George JR, Gray SB, Moss CW. Procedures for the production and separation of 'H' and 'M' antigens in histoplasmosis: Chemical and serological properties of the isolated products. Mycopath Mycol Appl 1977; 61: 131-141.
15. Kaufman L, Reise E. Serodiagnosis of fungal diseases. In: ER Lennet et al. (eds), Manual of Clinical Microbiology. Washington DC: Amer Soc Microbiol 1985; 924-944.
16. Bradford MM. A rapid and sensitive methods for quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Analytic Biochem 1976; 72: 248-254.
17. Lowry CH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with folin phenol reagent. J Biol Chem 1951; 9: 265-275.
18. Goodman NL, Sprouse RF, Larsh HW. Histoplasmin potency as affected by culture age. Subouradia 1968; 7: 1-11.
19. Fadulu SOB, Larsh HW. Biochemical characterization and skin test sensitivity of mycelial growth filtrate of Histoplasma duboisii. Amer J Trop Med Hyg 1972; 21: 110-119.
20. Cravan SA, Young CN. Histoplasmosis in South Africa; an update. Proc Int Spiel Congress 1993, Beijing, 194-196.